Oral Administration of Semicarbazide Limits Weight Gain together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue
Figure 1
Body weight changes in mice treated or not with orally administered semicarbazide. Two groups of age- and weight-matched mice were constituted after weaning and before oral administration of semicarbazide (week 0), given at 125 mg/100 mL in drinking solution (semidrinking, open triangles), while control (black symbols) had free access to tap water. Mean ± SEM of 8 determinations. Different from corresponding control at , , .
